PROPOFOL Drug Patent Profile
✉ Email this page to a colleague
When do Propofol patents expire, and what generic alternatives are available?
Propofol is a drug marketed by Avet Lifesciences, Dr Reddys, Hikma, Hospira, Innopharma, Sagent Pharms Inc, Teva Parenteral, and Watson Labs Inc. and is included in eight NDAs.
The generic ingredient in PROPOFOL is propofol. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the propofol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Propofol
A generic version of PROPOFOL was approved as propofol by SAGENT PHARMS INC on January 4th, 1999.
Summary for PROPOFOL
Recent Clinical Trials for PROPOFOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hartford Hospital | Phase 4 |
Charles University, Czech Republic | N/A |
Military University Hospital, Prague | N/A |
Pharmacology for PROPOFOL
Drug Class | General Anesthetic |
Physiological Effect | General Anesthesia |
Medical Subject Heading (MeSH) Categories for PROPOFOL
Anatomical Therapeutic Chemical (ATC) Classes for PROPOFOL
US Patents and Regulatory Information for PROPOFOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Avet Lifesciences | PROPOFOL | propofol | INJECTABLE;INJECTION | 206408-001 | Oct 12, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva Parenteral | PROPOFOL | propofol | INJECTABLE;INJECTION | 075392-001 | Sep 19, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | PROPOFOL | propofol | INJECTABLE;INJECTION | 077908-001 | Mar 17, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |